Loading company…
Overseed produces pharmaceutical-grade cannabis products for medical use.
Overseed produces therapeutic cannabis for pharmaceutical applications. Its products include dried cannabis flowers and full-spectrum extracts, and it offers collaborative research and development services. Founded in 2021 by CEO Hugues Peribère, the company is based in Orléans, France. In July 2024, it raised EUR 6.7 million in Series A funding led by Blast.Club and UI Investissement.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in